#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA643073	B	Inhibitory activity was tested against human recombinant ATP-Citrate Lyase (ACL) enzyme		1	ALA1131093	single protein format	Scientific Literature
2.	ALA643074	B	Inhibitory activity against human recombinant ATP-Citrate Lyase (ACL) enzyme		30	ALA1131093	single protein format	Scientific Literature
3.	ALA640438	B	Inhibitory activity was tested against rat ATP-Citrate Lyase (ACL) enzyme		2	ALA1131093	single protein format	Scientific Literature
4.	ALA696881	F	Inhibition of ATP levels in HepG2 cells was measured at 100 uM concentration.	Homo sapiens	2	ALA1131093	cell-based format	Scientific Literature
5.	ALA699381	F	Inhibition of cholesterol synthesis in HepG2 cells was measured at 100 uM concentration.	Homo sapiens	2	ALA1131093	cell-based format	Scientific Literature
6.	ALA699388	F	Inhibition of fatty acid synthesis in HepG2 cells was measured at 100 uM concentration.	Homo sapiens	2	ALA1131093	cell-based format	Scientific Literature
7.	ALA906357	B	Inhibition of human recombinant ATP-citrate lyase	Homo sapiens	13	ALA1139904	single protein format	Scientific Literature
8.	ALA925175	B	Inhibition of human ATP citrate lyase	Homo sapiens	1	ALA1140634	single protein format	Scientific Literature
9.	ALA2169034	B	Inhibition of rat liver ACLY	Rattus norvegicus	8	ALA2163275	assay format	Scientific Literature
10.	ALA2169035	B	Inhibition of human recombinant ACLY	Homo sapiens	7	ALA2163275	single protein format	Scientific Literature
11.	ALA4001976	B	Competitive inhibition of ATP citrate lyase (unknown origin) using sodium citrate as substrate by ADP-Glo luminescence assay	Homo sapiens	2	ALA4000242	single protein format	Scientific Literature
12.	ALA4275778	B	Inhibition of rat ACLY	Rattus norvegicus	1	ALA4270641	single protein format	Scientific Literature
13.	ALA4275779	B	Inhibition of human ACLY	Homo sapiens	2	ALA4270641	single protein format	Scientific Literature
14.	ALA4275782	F	In vivo inhibition of ACLY in po dosed rat assessed as reduction in plasma cholesterol level after 7 days relative to control	Rattus norvegicus	1	ALA4270641	organism-based format	Scientific Literature
15.	ALA4275783	F	In vivo inhibition of ACLY in po dosed rat assessed as reduction in plasma triglyceride level after 7 days relative to control	Rattus norvegicus	1	ALA4270641	organism-based format	Scientific Literature
16.	ALA4275784	F	In vivo inhibition of ACLY in po dosed dog assessed as reduction in plasma cholesterol level after 15 days relative to control	Canis lupus familiaris	1	ALA4270641	organism-based format	Scientific Literature
17.	ALA4275785	F	In vivo inhibition of ACLY in po dosed dog assessed as reduction in plasma triglyceride level after 15 days relative to control	Canis lupus familiaris	1	ALA4270641	organism-based format	Scientific Literature